COVID-19 pandemic: choosing a loose-fitting PAPR for better protection? Add an N95 FFR

Respected Editor,

Powered air-purifying respirator (PAPR) is a respirator that uses a blower to force air through filter cartridges or canisters into the breathing zone of the wearer through a tight-fitting half or full facepiece or a loose-fitting facepiece, hood, or helmet (Centre for Disease Control 2020).

Loose-fitting National Institute for Occupational Safety and Health (NIOSH)-approved PAPRs have several advantages over tight-fitting non-powered respirators (Centre for Disease Control 2020). They are:

1. PAPR systems have Assigned Protection Factor (APF) of at least 25 (may up to 1000) while N95 Filtering Facepiece Respirator (FFR) have an APF of 10 (Centre for Disease Control 2020). PAPRs are recommended for use in extremely aerosolizing procedures of the airway, lung, sinus, oropharynx, and skull base surgery (American Society of Anesthesiologists 2020).

2. Fit test is not needed (Centre for Disease Control 2020).

3. Splash protection for the face and eyes (Centre for Disease Control 2020).

4. Less taxing physiologically from a breathing resistance perspective than other respirators (Centre for Disease Control 2020).

In a loose-fitting PAPR, the exhaled air of the wearer is not passed through a filter. This exhaled air could contaminate the sterile surgical field and more importantly it could become source of infection to others.

Centre for Disease Control (CDC) has raised concerns about the use of PAPRs and respirators with exhalation valves for operating room (OR) use, because the exhaled air would not be filtered (American Society of Anesthesiologists 2020). Regular surgical mask may be worn under a PAPR or over the expiratory valve of the facemask respirator to afford standard protection from clinician’s exhaled air in OR (American Society of Anesthesiologists 2020).

Evidence suggests that SARS-CoV-2 transmission occurs from symptomatic and asymptomatic healthcare worker (HCW) to patients and other healthcare workers (Lucey et al. 2020). A HCW wearing a loose-fitting PAPR may become a source of infection during pre-symptomatic/asymptomatic phase or after returning back to work post-recovery. When the healthcare worker returns to work after recovering from the illness, the exact criteria that determine which HCWs will shed replication-competent virus for longer periods are not known (Centre for Disease Control 2020). On the other end, the wearer of a loose-fitting PAPR could become susceptible to infection during potential ‘No mask exposures’.

1. Immediately before donning the loose-fitting PAPR.

2. Until complete doffing and wearing a N95 FFR.

Surgical face masks protect against SARS-CoV-2 droplet transmission but not against aerosolized particles (American Society of Anesthesiologists 2020). When a loose-fitting PAPR is chosen for additional protection, it should not be used alone and it is prudent to wear a N95 FFR in addition (Fig. 1). If the HCW failed fit test for tight-fit respirators, it is a good practice to wear at least a surgical mask under a PAPR.

Fig. 1.

An Anesthesiologist wearing a N95 FFR along with loose-fitting PAPR. The arrows indicate the direction of the exhaled air escaping under loose-fitting hood but filtered through the N95 FFR

Wearing N95 FFR under a PAPR protects the wearer during donning and doffing and during mechanical or battery failure (Roberge et al. 2008), provides a sterile surgical field, and prevents infection spread to others. With increased production and availability of N95 FFR, this strategy of combining N95 FFR with loose-fitting PAPR is possible.

Abbreviations

COVID-19

Coronavirus disease—2019

SARS-CoV-2

Severe acute respiratory syndrome—coronavirus 2

PAPR

Powered air-purifying respirator

NIOSH

National Institute for Occupational Safety and Health

APF

Assigned Protection Factor

N95 FFR

N95 Filtering Facepiece Respirator

CDC

Centre for Disease Control

OR

Operating room

HCW

Healthcare worker

Authors’ contributions

OS—conceptualized, formally analysed, validated the use of N95 FFR along with PAPR, involved in original draft writing, review, and editing. VV—conceptualized, formally analysed, validated the use of N95 FFR along with PAPR, involved in original draft writing, review, and editing. AG—conceptualized, formally analysed, validated the use of N95 FFR along with PAPR, involved in original draft writing, review and editing. All authors read and approved the final manuscript.

Funding

Nil

Availability of data and materials

Not applicable

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

No patient involved in the study.

The Anesthesiologist in Fig. 1 is the first author and gives consent for the publication.

Competing interests

The authors declare that they have no competing interests.